Cargando…
Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen
BACKGROUND: Pharmacological high-throughput screening (HTS) represents a powerful strategy for drug discovery in genetic diseases, particularly when the full spectrum of pathological dysfunctions remains unclear, such as in Friedreich ataxia (FRDA). FRDA, the most common recessive ataxia, results fr...
Autores principales: | Calmels, Nadège, Seznec, Hervé, Villa, Pascal, Reutenauer, Laurence, Hibert, Marcel, Haiech, Jacques, Rustin, Pierre, Koenig, Michel, Puccio, Hélène |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744904/ https://www.ncbi.nlm.nih.gov/pubmed/19703283 http://dx.doi.org/10.1186/1471-2377-9-46 |
Ejemplares similares
-
The First Cellular Models Based on Frataxin Missense Mutations That Reproduce Spontaneously the Defects Associated with Friedreich Ataxia
por: Calmels, Nadège, et al.
Publicado: (2009) -
Frataxin levels in peripheral tissue in Friedreich ataxia
por: Lazaropoulos, Michael, et al.
Publicado: (2015) -
Friedreich's Ataxia, Frataxin, PIP5K1B: Echo of a Distant Fracas
por: Bayot, Aurélien, et al.
Publicado: (2013) -
Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich’s ataxia
por: Hackett, Peter T., et al.
Publicado: (2022) -
Neurodegeneration in Friedreich's Ataxia: From Defective Frataxin to Oxidative Stress
por: Gomes, Cláudio M., et al.
Publicado: (2013)